Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Paediatric Anaesthesia
|
February 8, 2012
Smartphone applications for pediatric anesthesia
Rahul Bhansali, James Armstrong
Pharmaceuticals (Basel, Switzerland)
|
December 22, 2019
Biological Characterization of 8-Cyclopropyl-2-(pyridin-3-yl)thiazolo[5,4-<i>f</i>]quinazolin-9(8<i>H</i>)-one, a Promising Inhibitor of DYRK1A
Corinne Fruit, Florence Couly, Rahul Bhansali, et al.
The Journal of Experimental Medicine
|
May 27, 2015
DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3
Benjamin J Thompson, Rahul Bhansali, Lauren Diebold, et al.
International Immunopharmacology
|
March 1, 2021
Caspase-1 inhibition ameliorates murine acute graft versus host disease by modulating the Th1/Th17/Treg balance
Wei Chen, GuiZhen Su, Yan Xu, et al.
Transplantation and Cellular Therapy
|
March 30, 2021
Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Immunoglobulin D Multiple Myeloma
Wei Chen, Ying Wang, Kunming Qi, et al.
Blood Cancer Journal
|
March 27, 2025
Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy
Reem Karmali, Geoffrey Shouse, Pallawi Torka, et al.
Cancers
|
July 29, 2025
Real World Outcomes of Patients with Aggressive Lymphoma and Autoimmune Disease Treated with CART
Nicole J Altomare, Megan M Herr, Nisha M Nair, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Paediatric Anaesthesia
|
February 8, 2012
Smartphone applications for pediatric anesthesia
Rahul Bhansali, James Armstrong
Pharmaceuticals (Basel, Switzerland)
|
December 22, 2019
Biological Characterization of 8-Cyclopropyl-2-(pyridin-3-yl)thiazolo[5,4-<i>f</i>]quinazolin-9(8<i>H</i>)-one, a Promising Inhibitor of DYRK1A
Corinne Fruit, Florence Couly, Rahul Bhansali, et al.
The Journal of Experimental Medicine
|
May 27, 2015
DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3
Benjamin J Thompson, Rahul Bhansali, Lauren Diebold, et al.
International Immunopharmacology
|
March 1, 2021
Caspase-1 inhibition ameliorates murine acute graft versus host disease by modulating the Th1/Th17/Treg balance
Wei Chen, GuiZhen Su, Yan Xu, et al.
Transplantation and Cellular Therapy
|
March 30, 2021
Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Immunoglobulin D Multiple Myeloma
Wei Chen, Ying Wang, Kunming Qi, et al.
Blood Cancer Journal
|
March 27, 2025
Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy
Reem Karmali, Geoffrey Shouse, Pallawi Torka, et al.
Cancers
|
July 29, 2025
Real World Outcomes of Patients with Aggressive Lymphoma and Autoimmune Disease Treated with CART
Nicole J Altomare, Megan M Herr, Nisha M Nair, et al.
Page
of 1